Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PXLW
|
Todd Debonis
President and CEO |
SELL
Open market or private sale
|
Direct | 41,884 Reduced 2.41% |
$30,994
$0.74 p/Share
|
Nov 20
2024 |
|
CMCSA
|
Wonya Y Lucas
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 31.99% |
-
|
Nov 20
2024 |
|
CMCSA
|
Asuka Nakahara
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 9.42% |
-
|
Nov 20
2024 |
|
PLXS
|
Michael J. Running
Regional President - AMER |
SELL
Open market or private sale
|
Direct | 539 Reduced 34.35% |
$84,013
$155.87 p/Share
|
Nov 20
2024 |
|
INVA
|
Marianne Zhen
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 976 Reduced 2.13% |
$18,690
$19.15 p/Share
|
Nov 20
2024 |
|
CMCSA
|
David C Novak
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 1.38% |
-
|
Nov 20
2024 |
|
IVFH
|
Samuel Klepfish
Director |
SELL
Open market or private sale
|
Direct | 127,436 Reduced 5.02% |
$203,897
$1.6 p/Share
|
Nov 20
2024 |
|
CTRA
|
Stephen P Bell
EVP - Business Development |
SELL
Bona fide gift
|
Direct | 84,615 Reduced 16.83% |
-
|
Nov 20
2024 |
|
DXCM
|
Sadie Stern
EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct | 4,259 Reduced 5.64% |
$318,275
$74.73 p/Share
|
Nov 20
2024 |
|
CTRA
|
Adam M Vela
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 16,435 Reduced 18.5% |
$439,800
$26.76 p/Share
|
Nov 20
2024 |
|
IBEX
|
Pine Bridge Gem Ii G.P., L.P. |
SELL
Open market or private sale
|
Indirect | 78,728 Reduced 0.0% |
$1,584,007
$20.12 p/Share
|
Nov 20
2024 |
|
SILO
|
Eric Weisblum
CEO and President |
BUY
Open market or private purchase
|
Direct | 2,500 Added 1.35% |
$2,375
$0.95 p/Share
|
Nov 20
2024 |
|
NWN
|
Karen Lee |
BUY
Discretionary transaction
|
Indirect | 1,156 Added 0.0% |
$48,690
$42.12 p/Share
|
Nov 20
2024 |
|
REZI
|
Robert B Aarnes
President, ADI |
SELL
Open market or private sale
|
Direct | 98,829 Reduced 17.72% |
$2,585,366
$26.16 p/Share
|
Nov 20
2024 |
|
REZI
|
Robert B Aarnes
President, ADI |
BUY
Exercise of conversion of derivative security
|
Direct | 98,829 Added 15.05% |
$1,712,706
$17.33 p/Share
|
Nov 20
2024 |
|
WPC
|
Brian H Zander
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 440 Reduced 5.73% |
$24,926
$56.65 p/Share
|
Nov 20
2024 |
|
KEYS
|
Neil Dougherty
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,573 Reduced 3.26% |
$591,260
$165.48 p/Share
|
Nov 20
2024 |
|
KEYS
|
Neil Dougherty
EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 20,639 Added 14.74% |
-
|
Nov 20
2024 |
|
RSMDF
|
Carol Burt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,083 Added 27.53% |
-
|
Nov 20
2024 |
|
KEYS
|
Ingrid A Estrada
SVP |
SELL
Payment of exercise price or tax liability
|
Direct | 1,985 Reduced 1.87% |
$328,477
$165.48 p/Share
|
Nov 20
2024 |
|
KEYS
|
Ingrid A Estrada
SVP |
BUY
Grant, award, or other acquisition
|
Direct | 12,317 Added 9.88% |
-
|
Nov 20
2024 |
|
KEYS
|
Mark Adam Wallace
SVP |
SELL
Payment of exercise price or tax liability
|
Direct | 1,629 Reduced 1.77% |
$269,566
$165.48 p/Share
|
Nov 20
2024 |
|
KEYS
|
Mark Adam Wallace
SVP |
BUY
Grant, award, or other acquisition
|
Direct | 5,481 Added 5.63% |
-
|
Nov 20
2024 |
|
KEYS
|
Sung Yoon
SVP |
SELL
Payment of exercise price or tax liability
|
Direct | 28 Reduced 0.35% |
$4,633
$165.48 p/Share
|
Nov 20
2024 |
|
KEYS
|
Sung Yoon
SVP |
BUY
Grant, award, or other acquisition
|
Direct | 4,016 Added 26.11% |
-
|
Nov 20
2024 |
|
KEYS
|
Jeffrey K Li
SVP and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,738 Reduced 5.94% |
$287,604
$165.48 p/Share
|
Nov 20
2024 |
|
KEYS
|
Jeffrey K Li
SVP and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 11,028 Added 23.93% |
-
|
Nov 20
2024 |
|
KEYS
|
Soon Chai Gooi
SVP |
BUY
Grant, award, or other acquisition
|
Direct | 18,013 Added 6.53% |
-
|
Nov 20
2024 |
|
NWN
|
Mary E Ludford |
BUY
Discretionary transaction
|
Indirect | 861 Added 0.0% |
$36,265
$42.12 p/Share
|
Nov 20
2024 |
|
KEYS
|
Satish Dhanasekaran
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 46,814 Added 25.83% |
-
|
Nov 20
2024 |
|
KEYS
|
Satish Dhanasekaran
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,012 Reduced 6.45% |
$1,160,345
$165.48 p/Share
|
Nov 20
2024 |
|
IMVT
|
Eva Renee Barnett
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,174 Reduced 1.24% |
$106,228
$25.45 p/Share
|
Nov 20
2024 |
|
DASH
|
Andy Fang |
SELL
Open market or private sale
|
Direct | 1,913 Reduced 10.58% |
$326,625
$170.74 p/Share
|
Nov 20
2024 |
|
DASH
|
Gordon S Lee
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 2,578 Reduced 2.66% |
$440,193
$170.75 p/Share
|
Nov 20
2024 |
|
DASH
|
Keith Yandell
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 7,980 Reduced 6.04% |
$1,363,223
$170.83 p/Share
|
Nov 20
2024 |
|
DASH
|
Prabir Adarkar
PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct | 19,898 Reduced 2.07% |
$3,399,175
$170.83 p/Share
|
Nov 20
2024 |
|
DASH
|
Ravi Inukonda
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 14,219 Reduced 3.6% |
$2,429,031
$170.83 p/Share
|
Nov 20
2024 |
|
DASH
|
Tia Sherringham
GENERAL COUNSEL AND SECRETARY |
SELL
Open market or private sale
|
Direct | 12,950 Reduced 8.15% |
$2,212,119
$170.82 p/Share
|
Nov 20
2024 |
|
DASH
|
Stanley Tang |
SELL
Open market or private sale
|
Direct | 1,855 Reduced 4.98% |
$316,741
$170.75 p/Share
|
Nov 20
2024 |
|
CMCSA
|
Kenneth J Bacon
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 81 Reduced 0.17% |
$3,482
$42.99 p/Share
|
Nov 20
2024 |
|
CMCSA
|
Kenneth J Bacon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 9.98% |
-
|
Nov 20
2024 |
|
CMCSA
|
Thomas J Baltimore Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 19.94% |
-
|
Nov 20
2024 |
|
IMVT
|
William L. Macias
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,353 Reduced 0.92% |
$85,333
$25.45 p/Share
|
Nov 20
2024 |
|
CMCSA
|
Madeline S. Bell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 12.18% |
-
|
Nov 20
2024 |
|
IMVT
|
Mark S. Levine
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,650 Reduced 1.13% |
$92,892
$25.45 p/Share
|
Nov 20
2024 |
|
HD
|
Ann Marie Campbell
Senior EVP |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.0% |
$40,258
$402.58 p/Share
|
Nov 20
2024 |
|
CMCSA
|
Louise F. Brady
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 25.64% |
-
|
Nov 20
2024 |
|
CMCSA
|
Edward D Breen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 17.12% |
-
|
Nov 20
2024 |
|
BRX
|
Steven F Siegel
Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 7.35% |
$738,500
$29.54 p/Share
|
Nov 20
2024 |
|
CMCSA
|
Jeffrey A Honickman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,234 Added 2.28% |
-
|
Nov 20
2024 |